doi: 10.1002/ana.410240417.
Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia
Affiliations
- PMID: 2977086
- DOI: 10.1002/ana.410240417
Item in Clipboard
Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia
Ann Neurol.
1988 Oct.
Abstract
The concentration of the endogenous excitotoxin quinolinic acid was determined in the cerebrospinal fluid of drug-free patients suffering from Huntington's disease or schizophrenia (control group). In both diseases, quinolinic acid concentrations were highly variable (less than 4-48 nM) but the mean levels for each disease group were not significantly different from each other or from the quinolinic acid concentration of normal cerebrospinal fluid. Analysis of steady-state cerebrospinal fluid quinolinic acid concentration is unlikely to be of value as a diagnostic tool in Huntington's disease.
Similar articles
-
Is there a viral or immune dysfunction etiology to schizophrenia? Re-evaluation a decade later.Schizophr Res. 1996 Oct 18;22(1):1-4. doi: 10.1016/0920-9964(96)00061-8. Schizophr Res. 1996. PMID: 8908685 Review. No abstract available.
-
Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.Ann Neurol. 1989 Aug;26(2):275-7. doi: 10.1002/ana.410260215. Ann Neurol. 1989. PMID: 2528321
-
Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.Ann Neurol. 1990 Jun;27(6):666-75. doi: 10.1002/ana.410270614. Ann Neurol. 1990. PMID: 2163238
-
The quinolinic acid hypothesis in Huntington's chorea.J Neurol Sci. 1990 Jan;95(1):29-38. doi: 10.1016/0022-510x(90)90114-3. J Neurol Sci. 1990. PMID: 2159984 Review.
-
Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease.Neurosci Lett. 1991 Jan 28;122(2):265-9. doi: 10.1016/0304-3940(91)90874-s. Neurosci Lett. 1991. PMID: 1827518
Cited by
-
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.J Neurochem. 2021 Jul;158(2):539-553. doi: 10.1111/jnc.15360. Epub 2021 May 5. J Neurochem. 2021. PMID: 33797782 Free PMC article.
-
Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment.Evol Med Public Health. 2019 Aug 26;2019(1):149-168. doi: 10.1093/emph/eoz022. eCollection 2019. Evol Med Public Health. 2019. PMID: 31548888 Free PMC article. Review.
-
A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.J Huntingtons Dis. 2018;7(2):109-135. doi: 10.3233/JHD-170273. J Huntingtons Dis. 2018. PMID: 29614689 Free PMC article. Review.
-
Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.Int J Tryptophan Res. 2017 Mar 15;10:1178646917691938. doi: 10.1177/1178646917691938. eCollection 2017. Int J Tryptophan Res. 2017. PMID: 28469468 Free PMC article. Review.
-
Tryptophan Metabolism in Rat Liver After Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors.Int J Tryptophan Res. 2016 Aug 11;9:51-65. doi: 10.4137/IJTR.S38190. eCollection 2016. Int J Tryptophan Res. 2016. PMID: 27547037 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
etc
LinkOut - more resources
Full Text Sources
Medical
